“…[19,[31][32][33][34] Currently, particles with a size in the micro-or nanometer scale have been widely applied in cell delivery, cell targeting, and bioimaging. [35] From the viewpoint of applications in biotechnology, the particles must meet several requirements: i) precise control of particle composition and sizes across the endocytic/phagocytic size ranges, ii) prevention of particle-to-particle aggregation and fusion, iii) control of the surface chemistry for functionalization and dispersion, and iv) biocompatibility and low toxicity. [36] Although semiconductor quantum dots [37][38][39][40] or nanorods [41] have been developed to address the gap, their disadvantages, such as toxity (they could not be biocompatible until conjugated with polymers [42] or coated with silica [43] ), inefficient delivery, short circulation half life for in vivo imaging, [42] limit their widespread application.…”